Log in to save to my catalogue

TET1 promotes growth of T-cell acute lymphoblastic leukemia and can be antagonized via PARP inhibiti...

TET1 promotes growth of T-cell acute lymphoblastic leukemia and can be antagonized via PARP inhibiti...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2486293887

TET1 promotes growth of T-cell acute lymphoblastic leukemia and can be antagonized via PARP inhibition

About this item

Full title

TET1 promotes growth of T-cell acute lymphoblastic leukemia and can be antagonized via PARP inhibition

Publisher

London: Nature Publishing Group UK

Journal title

Leukemia, 2021-02, Vol.35 (2), p.389-403

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematological cancer characterized by skewed epigenetic patterns, raising the possibility of therapeutically targeting epigenetic factors in this disease. Here we report that among different cancer types, epigenetic factor
TET1
is highly expressed in T-ALL and is crucial for human T...

Alternative Titles

Full title

TET1 promotes growth of T-cell acute lymphoblastic leukemia and can be antagonized via PARP inhibition

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2486293887

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2486293887

Other Identifiers

ISSN

0887-6924

E-ISSN

1476-5551

DOI

10.1038/s41375-020-0864-3

How to access this item